By modulating the cellular localization of BRCA1, PRMT1 is an important regulator of the oncogenic functions of BRCA1, contributing to the epigenetic defense of breast cancer cells against ionizing radiation, and PRMT1-mediated methylation of BRCA1 is known to facilitate resistance to radiation therapy [47] (Figure 2). This evidence concerns the gene BRCA1 and breast carcinoma.